Accessibility settings

This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (1170) Pharmacovigilance (236) Pharmacology and Pharmaceutics (157) Immunology, Allergy, Rheumatology (182) Infectious Diseases (non-STD/STI) (1890) Pilot studies (non-ehealth) (234)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/88069, first published .
Close-up of a person's back with a rash or skin discoloration

Dovramilast for Erythema Nodosum Leprosum in Patients With Leprosy in Nepal: Protocol for a Phase 2 Open-Label Pilot Study

Dovramilast for Erythema Nodosum Leprosum in Patients With Leprosy in Nepal: Protocol for a Phase 2 Open-Label Pilot Study

Authors of this article:

Mahesh Shah1 Author Orcid Image ;   Divya RSJB Rana2 Author Orcid Image ;   Kapil Dev Neupane2 Author Orcid Image ;   Preeti Maharjan2 Author Orcid Image ;   Suwash Baral1 Author Orcid Image ;   Reejana Shrestha1 Author Orcid Image ;   Jivan Shakya2 Author Orcid Image ;   Binod Aryal2 Author Orcid Image ;   Bishwanath Acharya2 Author Orcid Image ;   Indra Bahadur Napit2 Author Orcid Image ;   Deanna A Hagge3 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.